Revenue
2016
2017
2018
2019
2020
2021
2022
2023
CONSTELLIUM SE (CSTM)
Price—Loading quote
Net income
2016
2017
2018
2019
2020
2021
2022
2023
Free cash flow
2016
2017
2018
2019
2020
2021
2022
2023
Total cash / debt
CashTotal debt
2016
2017
2018
2019
2020
2021
2022
2023
Financial statements
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | €7.24B | €8.12B | €6.15B | €4.88B | €5.91B | €5.69B | €5.24B | €4.74B | €5.15B |
| Gross profit | €710.0M | €672.0M | €664.0M | €490.0M | €602.0M | €538.0M | €555.0M | €535.0M | €450.0M |
| Research & development | €52.0M | €48.0M | €39.0M | €39.0M | €48.0M | €40.0M | €36.0M | €31.0M | €35.0M |
| Operating expenses | €6.90B | €7.79B | €5.67B | €4.76B | €5.65B | €5.28B | €4.90B | €4.48B | €5.58B |
| Operating income | €337.0M | €334.0M | €484.0M | €125.0M | €255.0M | €404.0M | €338.0M | €267.0M | −€426.0M |
| EBITDAderived | €631.0M | €621.0M | €751.0M | €384.0M | €511.0M | €601.0M | €509.0M | €422.0M | −€286.0M |
| Net income | €125.0M | €301.0M | €257.0M | −€21.0M | €59.0M | €188.0M | −€31.0M | −€4.0M | −€554.0M |
| Basic EPSper diluted share | €0.85 | €2.10 | €1.82 | -€0.15 | €0.43 | €1.40 | -€0.28 | -€0.04 | -€5.27 |
| Diluted EPSper diluted share | €0.84 | €2.06 | €1.75 | -€0.15 | €0.41 | €1.37 | -€0.28 | -€0.04 | -€5.27 |
Insider buys & sells
| Transaction | Insider | Type | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| Jun 4, 2026Form 4 | Ormerod JohnDirector | SellOrdinary shares | 8.0K | $35.01 | $280.1K | 24.9K |
| May 28, 2026Form 4 | Becker MarcusSVP CPO | SellOrdinary shares | 10.4K | $34.93 | $363.0K | 16.8K |
| May 14, 2026Form 4 | Jarrett MartinSVP Chief Innovation Officer | SellOrdinary shares | 4.7K | $33.46 | $157.8K | 15.4K |
| May 14, 2026Form 4 | Soultz Bradley LeeDirector | BuyOrdinary shares · indirect | 2.5K | $33.84 | $84.6K | 2.5K |
| May 12, 2026Form 4 | Piquier LudovicSVP Manuf Excellence & CTO | SellOrdinary shares | 1.0K | $33.57 | $33.6K | 241.7K |